-
1 Comment
Kangyue Technology Co., Ltd is currently in a long term uptrend where the price is trading 45.5% above its 200 day moving average.
From a valuation standpoint, the stock is 4.7% cheaper than other stocks from the Consumer Cyclical sector with a price to sales ratio of 4.9.
Kangyue Technology Co., Ltd's total revenue rose by 114.9% to $276M since the same quarter in the previous year.
Its net income has increased by 144.6% to $8M since the same quarter in the previous year.
Finally, its free cash flow fell by 53.5% to $19M since the same quarter in the previous year.
Based on the above factors, Kangyue Technology Co., Ltd gets an overall score of 4/5.
| Industry | Drug Manufacturers - Specialty & Generic |
|---|---|
| CurrencyCode | CNY |
| ISIN | CNE100001XN8 |
| Sector | Healthcare |
| Exchange | SHE |
| Beta | 0.21 |
|---|---|
| Target Price | None |
| Market Cap | 2B |
| PE Ratio | None |
| Dividend Yield | None |
Changjiang Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the production and distribution of pharmaceuticals and photovoltaic equipment in China and internationally. It offers photovoltaic equipment, such as laminating machines and stitch welding machines; tablets and hollow capsules; and Chinese herbal beverages, as well as engages in pharmaceutical distribution business. The company was formerly known as Kangyue Technology Co., Ltd. and changed its name to Changjiang Pharmaceutical Group Co., Ltd. in March 2023. Changjiang Pharmaceutical Group Co., Ltd. was founded in 1963 and is based in Shouguang, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 300391.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
